Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ning Ma & Lianqun Cui. (2015) Comparative efficacy of pitavastatin and simvastatin in patients with hypercholesterolemia: a meta-analysis of randomized controlled clinical trials. Drug Design, Development and Therapy 9, pages 1859-1864.
Read now
Read now
Hirokazu Kakuda, Munetoshi Matoba, Hideaki Nakatoh, Shin Nagao & Noboru Takekoshi. (2014) Comparison of atorvastatin, pitavastatin and rosuvastatin for residual cardiovascular risk using non-fasting blood sampling. Scandinavian Journal of Clinical and Laboratory Investigation 74:4, pages 285-295.
Read now
Read now
Miao Hu & Brian Tomlinson. (2014) Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin. Expert Opinion on Drug Metabolism & Toxicology 10:1, pages 51-65.
Read now
Read now
Vivencio Barrios, Carlos Escobar & José L Zamorano. (2013) Searching the place of pitavastatin in the current treatment of patients with dyslipidemia. Expert Review of Cardiovascular Therapy 11:12, pages 1597-1612.
Read now
Read now
Stella Aslibekyan, Robert J Straka, Marguerite R Irvin, Steven A Claas & Donna K Arnett. (2013) Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies. Expert Review of Cardiovascular Therapy 11:3, pages 355-364.
Read now
Read now
Ken Kishida, Tohru Funahashi & Iichiro Shimomura. (2013) Effects of pitavastatin on HDL metabolism. Clinical Lipidology 8:1, pages 55-68.
Read now
Read now
Articles from other publishers (13)
Hina Arsh, Asif Ali, Raja Ram Khenhrani, FNU Simran, Umbish Dino, Sweta Tamang, FNU Manoj, Shuaita Bai, Monika Bai, Gianeshwareealias Rachna Panjwani, Deepak Kumar, Deepa Rani, FNU Partab & Jahanzeb Malik. (2023) Efficacy and Safety of Pitavastatin in Patients with Impaired Glucose Tolerance: An Updated Review. Current Problems in Cardiology 48:11, pages 101981.
Crossref
Crossref
Cong Lu, Lu Fang, Yujie Zhu, Lemin Zheng & Donghui Liu. 2023. Statins - From Lipid-Lowering Benefits to Pleiotropic Effects. Statins - From Lipid-Lowering Benefits to Pleiotropic Effects.
Abdullah Shehab, Asim Ahmed Elnour, Akshaya Srikanth Bhagavathula, Joseph Pulavelil Kurian, Gazi Hassan, Shareen AlZaabi, Huburt Gilbert & Khalid Al-Rasadi. (2021) A Multicenter Prospective Hospital-based Cohort Study on the Efficacy and Safety of Pitavastatin. Current Diabetes Reviews 17:7.
Crossref
Crossref
Hui Liu, Mingjun Zhang, Delong Li, Jingjing Tian, Xuyang Wang, Jinyu Pan, Dian Liu, Xiaowei Li & Fengshuang An. (2018) Effect of pitavastatin and atorvastatin on regression of atherosclerosis assessed using intravascular ultrasound. Coronary Artery Disease 29:6, pages 459-468.
Crossref
Crossref
Angela Pirillo & Alberico L. Catapano. (2017) Pitavastatin and HDL: Effects on plasma levels and function(s). Atherosclerosis Supplements 27, pages e1-e9.
Crossref
Crossref
Vivencio Barrios & Carlos Escobar. (2016) Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes. Future Cardiology 12:4, pages 449-466.
Crossref
Crossref
Shigemasa Tani, Atsuhiko Takahashi, Ken Nagao & Atsushi Hirayama. (2014) Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins: comparative study of pitavastatin and atorvastatin. Heart and Vessels 30:6, pages 762-770.
Crossref
Crossref
Daniel E. Abbott, Jeffrey M. Sutton & Michael J. Edwards. (2014) Making the case for cost-effectiveness research. Journal of Surgical Oncology 109:6, pages 509-515.
Crossref
Crossref
Sayaka KAWANO, Johji KATO & Kazuo KITAMURA. (2014) Clinical features of patients with statin-related myopathy. Health Evaluation and Promotion 41:4, pages 548-553.
Crossref
Crossref
Peter J. Little, Alan Chait, Andrzej S. Januszewski, Alex Bobik, David O’Neal & Alicia J. Jenkins. 2014. Lipoproteins in Diabetes Mellitus. Lipoproteins in Diabetes Mellitus
435
453
.
Jennifer A. Shannon, Samuel M. John, Harish S. Parihar, Shari N. Allen & Jenna J. Ferrara. (2013) A Clinical Review of Statin-Associated Myopathy. Journal of Pharmacy Technology 29:5, pages 219-230.
Crossref
Crossref
Robert H. Nelson. (2013) Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Primary Care: Clinics in Office Practice 40:1, pages 195-211.
Crossref
Crossref
Ki-Hoon HanHyo-Jin KimJae Joong Kim. (2012) Cost-effectiveness of the Use of Statins in the Korean Population. Journal of Lipid and Atherosclerosis 1:2, pages 87.
Crossref
Crossref